Sigilon Therapeutics, Inc.
SGTX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$44 | -$77 | -$55 | -$44 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | -$1 | $0 |
| Stock-Based Comp. | $6 | $6 | $3 | $2 |
| Change in WC | -$19 | -$13 | -$3 | -$11 |
| Other Non-Cash | $4 | $5 | -$8 | $2 |
| Operating Cash Flow | -$51 | -$78 | -$62 | -$50 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$43 | -$16 | $0 | $0 |
| Inv. Sales/Matur. | $31 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12 | -$18 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | -$1 | $133 | $0 |
| Stock Repurch. | $0 | -$1 | $52 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | $2 | $189 | $63 |
| Financing Cash Flow | -$2 | $2 | $189 | $63 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$65 | -$95 | $127 | $12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $109 | $203 | $77 | $65 |
| End Cash | $43 | $109 | $203 | $77 |
| Free Cash Flow | -$52 | -$80 | -$63 | -$51 |